Disparities of trastuzumab use in resources limited or abundant regions and its survival benefit on HER2 positive breast cancer: a real world research from China

著录项

• 来源
  《The Breast :》 |2017年第2017期|共1页
• 作者

  Li J.; Zhang H.; Wang S.; Wang Y.; Wang X.; Wang H.; Feng J.; Zhang Q.; Sun T.; Jiang Z.;

  展开▼
• 作者单位

  PLA Mil Med Sci Acad Affiliated Hosp Beijing Peoples R China;

  PLA Mil Med Sci Acad Affiliated Hosp Beijing Peoples R China;

  Sun Yat Sen Univ Ctr Canc Guangzhou Guangdong Peoples R China;

  ShanDong Prov Tumor Hosp Jinan Shandong Peoples R China;

  ZheJiang Prov Tumor Hosp Hangzhou Zhejiang Peoples R China;

  Qingdao Univ Affiliated Hosp Qingdao Peoples R China;

  JiangSu Prov Tumor Hosp Nanjing Jiangsu Peoples R China;

  Harbin Med Univ Affiliated Hosp Harbin Peoples R China;

  LiaoNing Prov Tumor Hosp Liaoning Peoples R China;

  PLA Mil Med Sci Acad Affiliated Hosp Beijing Peoples R China;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 胸部外科学;
• 关键词